US Myocardial Infarction Market Size, Share & Trends Analysis Report and Forecast, 2022-2028
The US myocardial infarction (MI) market is estimated to grow modestly at a CAGR of around 6.4% during the forecast period. The US contributes significantly to the growth of the MI treatment market in North America. The increasing prevalence of heart diseases, high per capita healthcare expenditure and well-developed healthcare infrastructure are the key factors to promote the growth of the myocardial infarction treatment market in the US. The US is expected to make a major contribution to the MI treatment market due to the rise in the adoption of hybrid operating rooms and innovative treatment technology. Hospitals and clinics in the US are well equipped with the latest treatment devices which are essential to perform critical MI surgeries. Cleveland Clinic, Mayo Clinic, New York-Presbyterian University Hospital of Columbia and Cornell are some of the key hospitals contributing to the growth of the MI treatment market. In 2019, the average cardiology procedures which include bypass surgery ranges from $56,000 to $200,000 in the US. The cost of heart valve replacement surgery costs around $80,000- $200,000. Additionally, various physical therapies followed by surgery may cost around $50-$350 per session, according to the Center for Medicare & Medicaid Services.
Get Free Sample link @ https://www.omrglobal.com/request-sample/us-myocardial-infarction-market
The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST segment elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into a left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.
A full report of US Myocardial Infarction Market available @ https://www.omrglobal.com/industry-reports/us-myocardial-infarction-market
· Market Coverage
· Market number available for – 2022-2028
· Base year- 2021
· Forecast period- 2022-2028
· Segment Covered- By Source, By Product Type, By Applications
· Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
US Myocardial Infarction Market by Type
o Non-ST-elevation myocardial infarction (NSTEMI)
o ST-elevation myocardial infarction (STEMI)
o Silent Heart Attacks
US Myocardial Infarction Market by Device
o Left Ventricular Assist Device (LVAD)
o Pacemaker
o Catheters
o Implantable Cardioverter-Defibrillator (ICD)
o Others (Stent Graft)
US Myocardial Infarction Market by Diagnosis
o Electrocardiography (ECG)
o Chest X-Ray
o Computed Tomography (CT Scan)
o Echocardiography
o Others (Blood Test)
US Myocardial Infarction Market by Treatment
o Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Beta-Adrenergic Blockers)
o Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant
US Myocardial Infarction Market by End-User
o Hospital & Clinics
o Ambulatory Surgical Centers
o Research Institutes
Company Profiles
o Abbott Laboratories Inc.
o AstraZeneca PLC
o Athersys Inc.
o Bayer AG
o Biovascular Inc.
o Boston Scientific Corp.
o Bristol-Myers Squibb Co.
o Caladrius Bioscience Inc.
o Capricor Therapeutics, Inc.
o Eli Lilly and Co.
o GlaxoSmithKline Plc
o Johnson & Johnson Services, Inc.
o Medtronic PLC
o Merck KGaA
o Mylan N.V.
o Novartis AG
o Osiris Therapeutics Inc.
o Pfizer Inc.
o Portola Pharmaceutical Inc.
o Siemens AG
o Ventrix, Inc.
The Report Covers
- Comprehensive research methodology of the US myocardial infarction market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the US myocardial infarction market.
- Insights about market determinants which are stimulating the US myocardial infarction market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-myocardial-infarction-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
